Indirubin is under investigation in clinical trial NCT01735864 (Dosage Determination Trial for Indigo Naturalis Extract in Oil Ointment).
Indirubin is under investigation in clinical trial NCT01735864 (Dosage Determination Trial for Indigo Naturalis Extract in Oil Ointment).
主要用于治疗慢性粒细胞白血病的慢性期患者,有少量报道初步认为本品对缩小伴有巨脾的骨髓纤维化患者脾脏亦可能有一定疗效。
No associated conditions information available.
Stay informed with timely notifications on clinical trials and research advancements.